GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zoetis Inc (LTS:0M3Q) » Definitions » Gross-Profit-to-Asset %

Zoetis (LTS:0M3Q) Gross-Profit-to-Asset % : 47.32% (As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Zoetis Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Zoetis's annualized Gross Profit for the quarter that ended in Sep. 2024 was $6,748 Mil. Zoetis's average Total Assets over the quarter that ended in Sep. 2024 was $14,261 Mil. Therefore, Zoetis's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2024 was 47.32%.


Zoetis Gross-Profit-to-Asset % Historical Data

The historical data trend for Zoetis's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zoetis Gross-Profit-to-Asset % Chart

Zoetis Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 38.24 36.72 39.79 39.04 40.96

Zoetis Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 43.45 41.84 43.22 47.50 47.32

Competitive Comparison of Zoetis's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Zoetis's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zoetis's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zoetis's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Zoetis's Gross-Profit-to-Asset % falls into.



Zoetis Gross-Profit-to-Asset % Calculation

Zoetis's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=5983/( (14925+14286)/ 2 )
=5983/14605.5
=40.96 %

Zoetis's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Sep. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=6748/( (14165+14357)/ 2 )
=6748/14261
=47.32 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Sep. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Zoetis Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Zoetis's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Zoetis Business Description

Address
10 Sylvan Way, Parsippany, NJ, USA, 07054
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Zoetis Headlines

No Headlines